LSKA Liska Biometry Inc (GM)

Liska Biometry (OTC BB:LSKA) a biometrics solutions provider, today announced the appointment of Brian E. Walsh to the position of Vice President of Global Solutions. Brian will oversee the sales and implementation of the Company's customized segment solutions. His responsibilities will include both direct and indirect sales, worldwide field support, field strategy and planning, and sales operations. Brian brings a very strong success record in technology sales and business development to Liska Biometry. Prior to joining the Company, Brian was Global Account Director for Magma Design Automation. His responsibilities included the development of strategic relationships with some of Magma's larger customers in the Northeast and Eastern Canada. Prior to that, he spent almost twelve years at Synopsys, Inc. where his most recent role was Director of Strategic Accounts. While at Synposys, Brian also served as Director of Sales for the Northeast and managed sales teams with continued expanded responsibilities. He has managed results from under $10M to over $80M. "Brian's appointment reflects Liska's commitment to filling senior management positions with key individuals who possess strong leadership skills and proven experience. Brian is an exceptional contributor and our business development initiatives will benefit from his diverse experience." commented Christopher J. LeClerc, President and CEO of Liska Biometry. Liska Biometry Safe Harbor Statement This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Liska Biometry, see "Risk Factors" in the Company's Annual Report on Form 10- KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.